[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$llys

$LLYs shows resilience near record levels, driven by healthcare innovation and metabolic treatments. Recent posts highlight strong management execution and positive developments in Alzheimer's research, including EMA approval for donanemab.

About $llys

$LLYs is a cryptocurrency project.

Engagements: XX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXX -XX%
X Month: XXXXXX +67%
X Months: XXXXXXX -XXXX%
X Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXXX on 2025-04-01
1-Year Low: X on 2025-06-05

Engagements by network (24h): X: XX

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Week: XX -XX%
X Month: XX +15%
X Months: XXX +57%
X Year: XXX +12%
1-Year High: XX on 2025-08-08
1-Year Low: X on 2025-01-12

Mentions by network (24h): X: X

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $llys in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: X
X Week: XX -XX%
X Month: XX +24%
X Months: XXX +47%
X Year: XXX +40%
1-Year High: XX on 2025-08-08
1-Year Low: X on 2025-01-12

Top $llys Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"yes Ascletis said when ASC30 was titrated weekly its vomiting rate was about half that of $LLY's oral GLP-1 orforglipron. The findings suggest "a potential best-in-class profile of ASC30 for both weight loss and GI tolerability" said Jinzi Jason Wu founder CEO and chairman of Ascletis"
X Link @chuminhua432 2025-12-09T09:17Z 3025 followers, XXX engagements

"CATALYST #1: 30+ FDA-APPROVED PRODUCTS XX new launches in 2024 alone (oncology critical care women's health) drove XX% revenue spike to $7.97M (9mo '24 XXXX% margins) Nicardilex crushes hypertension (19.4% PH deaths). Mirrors $LLY's Mounjaro magic but at penny prices"
X Link @KimchiAF 2025-12-03T20:05Z XXX followers, XX engagements